Immune System Diseases Recruiting Phase 1 Trials for CYNK-001 (DB15722)

Also known as: Immune System Disease

IndicationStatusPhase
DBCOND0029769 (Immune System Diseases)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04309084Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple MyelomaTreatment